LMAT Quote, Financials, Valuation and Earnings

Intuitive Surgical has a net margin of 18.39% compared to LeMaitre Vascular's net margin of 30.99%. LeMaitre Vascular's return on equity of 13.74% beat Intuitive Surgical's return on equity of 15.82%.

LeMaitre Vascular has a consensus price target of $104.50, signalling upside risk potential of 29.91%. On the other hand Intuitive Surgical has an analysts' consensus of $576.03 which suggests that it could grow by 8.31%. Given that LeMaitre Vascular has higher upside potential than Intuitive Surgical, analysts believe LeMaitre Vascular is more attractive than Intuitive Surgical.

LeMaitre Vascular has a beta of 0.859, which suggesting that the stock is 14.076% less volatile than S&P 500. In comparison Intuitive Surgical has a beta of 1.697, suggesting its more volatile than the S&P 500 by 69.708%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.85%. Intuitive Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Intuitive Surgical pays out -- of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $59.9M, which are smaller than Intuitive Surgical quarterly revenues of $2.3B. LeMaitre Vascular's net income of $11M is lower than Intuitive Surgical's net income of $698.4M. Notably, LeMaitre Vascular's price-to-earnings ratio is 40.63x while Intuitive Surgical's PE ratio is 77.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 8.12x versus 22.15x for Intuitive Surgical. Usually stocks with elevated PS ratios are considered overvalued.

Masimo has a net margin of 18.39% compared to LeMaitre Vascular's net margin of -58.2%. LeMaitre Vascular's return on equity of 13.74% beat Masimo's return on equity of -23.05%.

LeMaitre Vascular has a consensus price target of $104.50, signalling upside risk potential of 29.91%. On the other hand Masimo has an analysts' consensus of $195.70 which suggests that it could grow by 20.16%. Given that LeMaitre Vascular has higher upside potential than Masimo, analysts believe LeMaitre Vascular is more attractive than Masimo.

LeMaitre Vascular has a beta of 0.859, which suggesting that the stock is 14.076% less volatile than S&P 500. In comparison Masimo has a beta of 1.229, suggesting its more volatile than the S&P 500 by 22.855%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.85%. Masimo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Masimo pays out -- of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $59.9M, which are smaller than Masimo quarterly revenues of $600.7M. LeMaitre Vascular's net income of $11M is higher than Masimo's net income of -$349.6M. Notably, LeMaitre Vascular's price-to-earnings ratio is 40.63x while Masimo's PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 8.12x versus 4.21x for Masimo. Usually stocks with elevated PS ratios are considered overvalued.

Insulet has a net margin of 18.39% compared to LeMaitre Vascular's net margin of 16.85%. LeMaitre Vascular's return on equity of 13.74% beat Insulet's return on equity of 43.11%.

LeMaitre Vascular has a consensus price target of $104.50, signalling upside risk potential of 29.91%. On the other hand Insulet has an analysts' consensus of $313.60 which suggests that it could grow by 21.18%. Given that LeMaitre Vascular has higher upside potential than Insulet, analysts believe LeMaitre Vascular is more attractive than Insulet.

LeMaitre Vascular has a beta of 0.859, which suggesting that the stock is 14.076% less volatile than S&P 500. In comparison Insulet has a beta of 1.263, suggesting its more volatile than the S&P 500 by 26.336%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.85%. Insulet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Insulet pays out -- of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $59.9M, which are smaller than Insulet quarterly revenues of $597.5M. LeMaitre Vascular's net income of $11M is lower than Insulet's net income of $100.7M. Notably, LeMaitre Vascular's price-to-earnings ratio is 40.63x while Insulet's PE ratio is 44.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 8.12x versus 9.23x for Insulet. Usually stocks with elevated PS ratios are considered overvalued.

Teleflex has a net margin of 18.39% compared to LeMaitre Vascular's net margin of 13.56%. LeMaitre Vascular's return on equity of 13.74% beat Teleflex's return on equity of 3.41%.

LeMaitre Vascular has a consensus price target of $104.50, signalling upside risk potential of 29.91%. On the other hand Teleflex has an analysts' consensus of $157.62 which suggests that it could grow by 28.25%. Given that LeMaitre Vascular has higher upside potential than Teleflex, analysts believe LeMaitre Vascular is more attractive than Teleflex.

LeMaitre Vascular has a beta of 0.859, which suggesting that the stock is 14.076% less volatile than S&P 500. In comparison Teleflex has a beta of 1.170, suggesting its more volatile than the S&P 500 by 17.034%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.85%. Teleflex offers a yield of 1.11% to investors and pays a quarterly dividend of $0.34 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Teleflex pays out 91.2% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $59.9M, which are smaller than Teleflex quarterly revenues of $700.7M. LeMaitre Vascular's net income of $11M is lower than Teleflex's net income of $95M. Notably, LeMaitre Vascular's price-to-earnings ratio is 40.63x while Teleflex's PE ratio is 38.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 8.12x versus 1.91x for Teleflex. Usually stocks with elevated PS ratios are considered overvalued.